Cephalon To Buy Swiss Drugmaker Mepha For $590M
The companies anticipate that the deal will close within the next 12 weeks, pending certain closing conditions and clearing antitrust hurdles, they announced in a joint statement.
The deal will double the size of Pennsylvania-based Cephalon's international business and diversify its product lineup. The combined company will have a presence in 100 countries, and 30 percent of its sales will...
To view the full article, register now.